Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of AMG 510 Tablets vs Water Dispersion
NCT05571163Phase 1Completed
- Sponsor
- Amgen
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sotorasib in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Amgen. Primary endpoints: Maximum Observed Plasma Concentration at Day 4, Area Under the Plasma Concentration-time Curve from Time Zero to Time of Last Quantifiable Concentration at Day 4 and 1 more. Started Mar 2020; status: completed.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05571163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05571163.